Summaries of the Section H (HML) update
Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.
The full Update will be available as a PDF on our website(external link)
The changes will be published in the online HML around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.
16 July 2021 - preview of changes for August 2021
|
Pharmaceutical |
Change |
|---|---|
|
Aciclovir (Aciclovir-Baxter) inj 250 mg vial |
price increase and addition of PSS |
|
Atenolol (Mylan Atenolol) tab 50 mg and 100 mg |
price increase and addition of PSS |
|
Atropine sulphate (Martindale) inj 600 mcg per ml, 1 ml ampoule |
price increase and addition of PSS |
|
Azithromycin (Apo-Azithromycin) tab 250 mg |
to be delisted 1 May 2022 |
|
Betamethasone valerate (Beta Cream) crm 0.1%, 50 g |
price increase and addition of PSS |
|
Betamethasone valerate (Beta Ointment) oint 0.1%, 50 g |
price increase and addition of PSS |
|
Betamethasone valerate (Beta Scalp) scalp app 0.1%, 100 ml |
price increase and addition of PSS |
|
Brimonidine tartrate (Arrow-Brimonidine) eye drops 0.2%, 5 ml |
price decrease and addition of PSS |
|
Cefepime inj 1 g and 2 g vial |
Brand change Cefepime Kabi – new listing and addition of PSS
Cefepime-AFT – to be delisted 1 January 2022 |
|
Cetirizine hydrochloride (Histaclear) oral liq 1mg per ml, 200 ml |
price decrease and addition of PSS |
|
Clonidine hydrochloride (Catapres) tab 150 mg |
price increase and addition of PSS |
|
Clonidine hydrochloride (Medsurge) inj 150 mg per ml, 1 ml ampoule |
price increase and addition of PSS |
|
Cyclophosphamide tab 50 mg |
Brand change
|
|
Dexamfetamine sulfate (PSM) tab 5 mg |
price increase and addition of PSS |
|
Dexamethasone (Dexmethsone) tab 0.5 mg and 4 mg |
price increase and addition of PSS |
|
Diclofenac sodium (Diclofenac Sandoz) tab EC 25 mg and 50 mg |
price increase and addition of PSS |
|
Diclofenac sodium (Apo-Diclo SR) tab long-acting 100 mg |
to be delisted 1 May 2022 |
|
Dopamine hydrochloride (Max Health Ltd) inj 40 mg per ml, 5 ml ampoule |
price increase and addition of PSS |
|
Doxorubicin hydrochloride (Doxorubicin Ebewe) inj 2 mg per ml, 100 ml vial |
price increase and addition of PSS |
|
Enteral feed 2 kcal/ml (Ensure Two Cal HN RTH) liquid 8.4 g protein, 21.9 g carbohydrate, 9.1 g fat and 0.5 g fibre per 100 ml, bottle, 1,000 ml |
new listing (p’code 2614162) |
|
Enteral feed 2 kcal/ml (Two Cal HN RTH) liquid 8.4 g protein, 21.9 g carbohydrate, 9.1 g fat and 0.5 g fibre per 100 ml, bottle, 200 ml |
to be delisted 1 February 2022 |
|
Epirubicin hydrochloride (Epirubicin Ebewe) inj 2 mg per ml, 100 ml vial |
price increase and addition of PSS |
|
Febuxostat tab 80 mg and 120 mg |
Brand change Febuxostat multichem – new listing and addition of HSS
Adenuric – to be delisted 1 January 2022 |
|
Felodipine tab long-acting 5 mg (Felo 5 ER) |
price increase and addition of PSS |
|
Felodipine tab long-acting 10 mg (Felo 10 ER) |
addition of PSS |
|
Fentanyl (Fentanyl Sandoz) patch 12.5 mcg per hour, 25 mcg per hour, 50 mcg per hour, 75 mcg per hour and 100 mcg per hour |
price increase and addition of PSS |
|
Flucloxacillin (AFT) grans for oral liq 25 mg per ml, 100 ml |
price increase and addition of PSS |
|
Flucloxacillin (AFT) grans for oral liq 50 mg per ml, 100 ml |
addition of PSS |
|
Glibenclamide (Daonil) tab 5 mg |
price increase and addition of PSS |
|
Glucose [dextrose] (HypoPak Glucose) oral soln 15 g per 80 ml sachet |
new listing and addition of HSS (p’code 2616394) |
|
Hydrocortisone with natamycin and neomycin (Pimafucort) crm 1% with natamycin 1% and neomycin sulphate 0.5%, 15 g |
to be delisted 1 May 2022 |
|
Ibuprofen tab long-acting 800 mg |
Brand change
|
|
Isoniazid (PSM) tab 100 mg |
price increase and addition of PSS |
|
Isoniazid with rifampicin (Rifanah) tab 100 mg with rifampicin 150 mg |
price increase |
|
Isoniazid with rifampicin (Rifanah) tab 150 mg with rifampicin 300 mg |
price increase and addition of PSS |
|
Letrozole (Letrole) tab 2.5 mg |
price increase and addition of PSS |
|
Low-GI oral feed 1 kcal/ml (Sustagen Diabetic (Vanilla)) liquid 4.5 g protein, 9.8 g carbohydrate, 4.4 g fat and 1.9 g fibre per 100 ml, can, 237 ml |
delisting delayed from 1 October 2021 to 1 February 2022 |
|
Macrogol 3350 with ascorbic acid, potassium chloride and sodium chloride (Glycoprep-C) powder for oral soln 755.68 mg with ascorbic acid 85.16 mg, potassium chloride 10.55 mg, sodium chloride 37.33 mg and sodium sulphate 80.62 mg per g, 70 g sachet |
new listing and addition of PSS (p’code 2586517) |
|
Magnesium hydroxide suspension 8% |
relocating listing and presentation description change |
|
Mebendazole (Vermox) tab 100 mg |
addition of PSS |
|
Megestrol acetate (Apo-Megestrol) tab 160 mg |
addition of restriction |
|
Meningococcal (A, C, Y and W-135) conjugate vaccine (Menactra) inj 4 mcg of each meningococcal polysaccharide conjugated to a total of approximately 48 mcg of diphtheria toxoid carrier per 0.5 ml vial |
amended restriction |
|
Meningococcal B multicomponent vaccine (Bexsero) inj 175 mcg per 0.5 ml prefilled syringe |
amended restriction |
|
Meningococcal C conjugate vaccine (Neisvac-C) inj 10 mcg in 0.5 ml syringe |
amended restriction |
|
Methadone hydrochloride (Biodone) oral liq 2 mg per ml |
price increase and addition of PSS |
|
Methadone hydrochloride (Biodone Forte) oral liq 5 mg per ml |
price increase and addition of PSS |
|
Methadone hydrochloride (Biodone Extra Forte) oral liq 10 mg per ml |
price increase and addition of PSS |
|
Methotrexate (Trexate) tab 2.5 mg and 10 mg |
price increase and addition of PSS |
|
Midazolam (Mylan Midazolam) inj 1 mg per ml, 5 ml ampoule and 5 mg per ml, 3 ml ampoule |
price increase and addition of PSS |
|
Mirtazapine tab 30 mg and 45 mg |
Brand change Noumed – new listing and addition of HSS
Apo-Mirtazapine – to be delisted 1 January 2022 |
|
Moclobemide (Aurorix) tab 150 mg and 300 mg |
price increase and addition of PSS |
|
Naproxen (Noflam 250) tab 250 mg |
addition of PSS |
|
Naproxen (Noflam 500) tab 500 mg |
price increase and addition of PSS |
|
Naproxen tab long-acting 750 mg (Naprosyn SR 750) and tab long-acting 1 g (Naprosyn SR 1000) |
price increase and addition of PSS |
|
Nevirapine (Nevirapine Alphapharm) tab 200 mg |
price increase and addition of PSS |
|
Nifedipine (Mylan 24 hr release) tab long-acting 30 mg and 60 mg |
brand name change |
|
Orphenadrine citrate (Norflex) tab 100 mg |
price increase and addition of PSS |
|
Oxytocin with ergometrine maleate (Syntometrine) inj 5 iu with ergometrine maleate 500 mcg per ml, 1 ml ampoule |
price increase and addition of PSS |
|
Paracetamol (Pacimol) tab 500 mg - blister pack |
new listing, presentation description change and addition of HSS (p’code 2612712) |
|
Pamidronate disodium (Pamisol) inj 9 mg per ml, 10 ml vial |
price increase |
|
Paraffin (e.g. QV Bath Oil) lotn liquid paraffin 85% |
new listing |
|
Perindopril (Apo-Perindopril) tab 2 mg and 4 mg |
to be delisted 1 October 2021 |
|
Pethidine hydrochloride (PSM) tab 50 mg |
price increase and addition of PSS |
|
Phenoxymethylpenicillin [penicillin V] (Cilicaine VK) tab 250 mg and 50 mg |
price increase and addition of PSS |
|
Pindolol (Apo-Pindolol) tab 5 mg, 10 mg and 15 mg |
addition of restriction and to be delisted from 1 May 2022 |
|
Pioglitazone (Vexazone) tab 15 mg, 30 mg and 45 mg |
price increase and addition of PSS |
|
Pirfenidone (Esbriet) tab 267 mg, 90 tab pack |
new listing (p’code 2602156) |
|
Pirfenidone (Esbriet) cap 267 mg, 270 cap pack |
to be delisted 1 January 2022 |
|
Prazosin (Apo-Prazosin) tab 1 mg, 2 mg and 5 mg |
addition of restriction and to be delisted 1 May 2022 |
|
Rasagiline (Azilect) tab 1 mg |
new listing and addition of PSS (p’code 2611449) |
|
Rituximab (Riximyo) inj 10 mg per ml, 10 ml and 50 ml vial |
amended restriction |
|
Salbutamol (Asthalin) nebuliser soln 1 mg per ml, 2.5 ml ampoule and 2 mg per ml, 2.5 ml ampoule |
price increase and addition of PSS |
|
Salbutamol with ipratropium bromide (Duolin) nebuliser soln 2.5 mg with ipratropium bromide 0.5 mg per 2.5 ml ampoule |
price increase and addition of PSS |
|
Selegiline hydrochloride tab 5 mg |
addition of restriction |
|
Sildenafil (Vedafil) tab 25 mg, 50 mg and 100 mg |
price increase and addition of PSS |
|
Sodium citrate (Biomed) oral liq 8.8% (300 mmol/l), 90 ml |
new listing and addition of PSS (p’code 345865) |
|
Sodium hyaluronate [hyaluronic acid] (Hylo-Fresh) eye drops 1 mg per ml, 10 ml |
Pharmacode change
|
|
Somatropin (Omnitrope) inj 5 mg and 15 mg cartridge |
price increase and addition of PSS |
|
Somatropin (Omnitrope) inj 10 mg cartridge |
addition of PSS |
|
Tobramycin (Tobramycin Mylan) inj 40 mg per ml, 2 ml vial |
price increase and addition of PSS |
|
Tretinoin (ReTrieve) crm 0.05%, 50 g |
price increase and addition of PSS |
|
Trimethoprim (TMP) tab 300 mg |
price increase and addition of PSS |
|
Trimethoprim with sulphamethoxazole [co-trimoxazole] (Trisul) tab 80 mg with sulphamethaxozole 400 mg |
new listing and addition of PSS (p’code 283363) |
|
Valaciclovir (Vaclovir) tab 500 mg and 1,000 mg |
price increase and addition of PSS |
|
Varenicline (Varenicline Pfizer) tab 0.5 mg x 11 and 1mg x 42, and tab 1 mg |
price decrease and addition of PSS |